NOVOS Age vs AgeRate Biological Age Test: Which Is Better in 2026?

For most people the smarter buy is NOVOS Age at $349. It delivers a multi-metric biological-age snapshot (epigenetic clock, telomeres, and a facial skin-age scan) with recommendations attached, at roughly a third of AgeRate's cost. AgeRate runs about $960, and that premium does not buy a better clock; it buys a program. AgeRate wraps a DNA-methylation reading inside an annual membership built around recurring, longitudinal tracking and a more hand-held experience. That is genuinely worth it for the person who knows they will commit to repeat testing and wants structure holding them to it. But if you want a single rigorous methylation reading, neither is the value leader; TruDiagnostic's TruAge is cheaper and more research-grade. So the honest framing: choose NOVOS for an accessible, affordable multi-metric baseline; choose AgeRate only if the membership-style, keep-me-accountable program is the point and you will actually use it. Remember that no biological-age test has been proven to predict how longevity interventions change your lifespan. Track the trend, not the headline number.

Both lean on DNA-methylation as the backbone of the biological-age estimate, but they package it very differently. NOVOS Age is a multi-metric one-time test: a methylation clock plus telomere length and a facial skin-age scan, blended into a single consumer-friendly readout with longevity recommendations. AgeRate is structured as a longitudinal membership, where the methylation test is the entry point to an ongoing, guided tracking program.

Cost is the sharpest divider:

That roughly $600 gap is not paying for a more accurate clock; both are consumer methylation products, not clinical research assays. AgeRate's spend goes toward the recurring cadence and concierge-style support, while NOVOS spreads its budget across multiple aging signals in one sitting. On experience, NOVOS emphasizes an approachable app and plan tie-in, whereas AgeRate's value hinges entirely on whether you engage with its repeat-testing structure. If you buy AgeRate and don't test again, you've overpaid for a single reading.

Choose NOVOS Age if you want an affordable, approachable biological-age baseline and like getting several aging signals (methylation, telomeres, skin scan) plus an actionable plan in one purchase.

Choose AgeRate if you know you will commit to recurring testing and want a structured, membership-style program that keeps you tracking over time. The premium only pays off if you use the longitudinal service.

Choose neither if you just want one rigorous methylation reading; a dedicated research-grade epigenetic test will give you more scientific depth for less than AgeRate's price.

Honest tradeoff: the underlying science is still maturing. Consumer biological-age clocks can shift between tests for reasons unrelated to real aging, and none has been shown to prove that a given intervention lengthens your life. Both products are best treated as trend-tracking tools over months and years, not as a definitive verdict on your health from a single number.